Assessing the benefits of health care: how far should we go?
作者信息
Ryan M, Shackley P
机构信息
Health Economics Research Unit, University of Aberdeen, Scotland.
出版信息
Qual Health Care. 1995 Sep;4(3):207-13. doi: 10.1136/qshc.4.3.207.
Abstract
摘要
相似文献
1
Assessing the benefits of health care: how far should we go?
Qual Health Care. 1995 Sep;4(3):207-13. doi: 10.1136/qshc.4.3.207.
2
User and carer participation in research in palliative care.
Palliat Med. 2005 Mar;19(2):91-2. doi: 10.1191/0269216305pm986ed.
3
The future of health economic modeling: have we gone too far or not far enough?
Value Health. 2006 May-Jun;9(3):179-80. doi: 10.1111/j.1524-4733.2006.00115.x.
4
The anatomy of cost estimates--the "other" outcome.
Adv Health Econ Health Serv Res. 1993;14:159-80.
5
Equity considerations in utility-based measures of health outcomes in economic appraisals: an adjustment algorithm.
J Health Econ. 1991 Oct;10(3):329-42. doi: 10.1016/0167-6296(91)90033-j.
6
Conducting pharmacoeconomic evaluations in a hospital setting.
Hosp Pharm. 1995 May;30(5):412, 415-6, 428.
7
Bringing health economic modeling to the 21st century.
Value Health. 2006 May-Jun;9(3):168-78. doi: 10.1111/j.1524-4733.2006.00097.x.
8
Assessing and developing the evidence base of macro practice interventions with a community and neighborhood focus.
J Evid Based Soc Work. 2008;5(3-4):519-47. doi: 10.1080/15433710802084284.
9
Are any numbers better than no numbers? The sorry state of willingness-to-pay and some major methodological shortcomings.
Aust Health Rev. 1992;15(2):135-44.
10
Patient satisfaction and quality of life humanistic outcomes.
Am J Manag Care. 1998 May;4(5):746-52; quiz 753-5.
引用本文的文献
1
Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.
Pharmacoeconomics. 2021 Dec;39(12):1383-1395. doi: 10.1007/s40273-021-01074-x. Epub 2021 Aug 23.
2
Social Prescribing in National Health Service Primary Care: What Are the Ethical Considerations?
Milbank Q. 2021 Sep;99(3):610-628. doi: 10.1111/1468-0009.12516. Epub 2021 Jun 25.
3
What is the right level of spending needed for health and care in the UK?
Lancet. 2021 May 22;397(10288):2012-2022. doi: 10.1016/S0140-6736(21)00230-0. Epub 2021 May 6.
4
Empirical Validity of a Generic, Preference-Based Capability Wellbeing Instrument (ICECAP-A) in the Context of Spinal Cord Injury.
Patient. 2021 Mar;14(2):223-240. doi: 10.1007/s40271-020-00451-6.
5
Using Nominal Group Technique to Identify Key Attributes of Oncology Treatments for a Discrete Choice Experiment.
MDM Policy Pract. 2019 Mar 20;4(1):2381468319837925. doi: 10.1177/2381468319837925. eCollection 2019 Jan-Jun.
6
An Investigation of the Overlap Between the ICECAP-A and Five Preference-Based Health-Related Quality of Life Instruments.
Pharmacoeconomics. 2017 Jul;35(7):741-753. doi: 10.1007/s40273-017-0491-7.
7
Development and preliminary user testing of the DCIDA (Dynamic computer interactive decision application) for 'nudging' patients towards high quality decisions.
BMC Med Inform Decis Mak. 2014 Aug 1;14:62. doi: 10.1186/1472-6947-14-62.
8
QALYs and carers.
Pharmacoeconomics. 2011 Dec;29(12):1015-23. doi: 10.2165/11593940-000000000-00000.
9
Cancer patients' willingness to pay for blood transfusions at home: results from a contingent valuation study in a French cancer network.
Eur J Health Econ. 2012 Jun;13(3):289-300. doi: 10.1007/s10198-011-0328-9. Epub 2011 Jun 10.
10
Development of a self-report measure of capability wellbeing for adults: the ICECAP-A.
Qual Life Res. 2012 Feb;21(1):167-76. doi: 10.1007/s11136-011-9927-2. Epub 2011 May 20.
本文引用的文献
1
Measurement of health state utilities for economic appraisal.
J Health Econ. 1986 Mar;5(1):1-30. doi: 10.1016/0167-6296(86)90020-2.
2
The imperative character of medical technology and the meaning of "anticipated decision regret".
Int J Technol Assess Health Care. 1989;5(2):207-13. doi: 10.1017/s0266462300006437.
3
The quality of QALYs (quality-adjusted-life-years): do QALYs measure what they at least intend to measure?
Health Policy. 1989 Oct;13(1):81-3. doi: 10.1016/0168-8510(89)90112-7.
4
Measuring handicap: the London Handicap Scale, a new outcome measure for chronic disease.
Qual Health Care. 1994 Mar;3(1):11-6. doi: 10.1136/qshc.3.1.11.
5
Agency in health care with an endogenous budget constraint.
J Health Econ. 1994 Jul;13(2):231-51. doi: 10.1016/0167-6296(94)90025-6.
6
QALYs (quality-adjusted life-years) versus HYEs (healthy years equivalents).
J Health Econ. 1993 Oct;12(3):311-23. doi: 10.1016/0167-6296(93)90014-6.
7
Implications of basing health-care resource allocations on cost-utility analysis in the presence of externalities.
J Health Econ. 1992 Oct;11(3):259-77. doi: 10.1016/0167-6296(92)90003-j.
8
Health related quality of life measurement--Euro style.
Health Policy. 1992;20(3):321-8; discussion 329-32. doi: 10.1016/0168-8510(92)90164-7.
9
QALY league tables: handle with care.
Health Econ. 1993 Apr;2(1):59-64. doi: 10.1002/hec.4730020108.
10
Sometimes sensitive, seldom specific: a review of the economics of screening.
Health Econ. 1993 Apr;2(1):43-53. doi: 10.1002/hec.4730020106.
Zotero 插件